Logo image of USM

US CELLULAR CORP (USM) Stock Fundamental Analysis

NYSE:USM - New York Stock Exchange, Inc. - US9116841084 - Common Stock - Currency: USD

65.42  -1.63 (-2.43%)

After market: 65.42 0 (0%)

Fundamental Rating

3

Overall USM gets a fundamental rating of 3 out of 10. We evaluated USM against 22 industry peers in the Wireless Telecommunication Services industry. USM may be in some trouble as it scores bad on both profitability and health. USM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

USM had positive earnings in the past year.
USM had a positive operating cash flow in the past year.
Of the past 5 years USM 4 years were profitable.
Of the past 5 years USM 4 years had a positive operating cash flow.
USM Yearly Net Income VS EBIT VS OCF VS FCFUSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

1.2 Ratios

USM has a Return On Assets of -0.29%. This is in the lower half of the industry: USM underperforms 71.43% of its industry peers.
With a Return On Equity value of -0.65%, USM is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 1.45%, USM is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for USM is significantly below the industry average of 6.52%.
The 3 year average ROIC (1.18%) for USM is below the current ROIC(1.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.29%
ROE -0.65%
ROIC 1.45%
ROA(3y)0.76%
ROA(5y)1.24%
ROE(3y)1.74%
ROE(5y)2.69%
ROIC(3y)1.18%
ROIC(5y)1.33%
USM Yearly ROA, ROE, ROICUSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6

1.3 Margins

In the last couple of years the Profit Margin of USM has declined.
With a Operating Margin value of 4.63%, USM is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
USM's Operating Margin has been stable in the last couple of years.
The Gross Margin of USM (56.96%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of USM has remained more or less at the same level.
Industry RankSector Rank
OM 4.63%
PM (TTM) N/A
GM 56.96%
OM growth 3Y-6.22%
OM growth 5Y0.84%
PM growth 3Y-37.54%
PM growth 5Y-18.23%
GM growth 3Y0.1%
GM growth 5Y0.31%
USM Yearly Profit, Operating, Gross MarginsUSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USM is destroying value.
There is no outstanding debt for USM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
USM Yearly Shares OutstandingUSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
USM Yearly Total Debt VS Total AssetsUSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

USM has an Altman-Z score of 1.43. This is a bad value and indicates that USM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.43, USM is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
USM has a debt to FCF ratio of 12.51. This is a negative value and a sign of low solvency as USM would need 12.51 years to pay back of all of its debts.
USM has a worse Debt to FCF ratio (12.51) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that USM is somewhat dependend on debt financing.
USM has a Debt to Equity ratio of 0.63. This is comparable to the rest of the industry: USM outperforms 52.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.51
Altman-Z 1.43
ROIC/WACC0.19
WACC7.52%
USM Yearly LT Debt VS Equity VS FCFUSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.57 indicates that USM should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.57, USM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.39 indicates that USM should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.39, USM is doing good in the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.39
USM Yearly Current Assets VS Current LiabilitesUSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 530.77% over the past year.
The earnings per share for USM have been decreasing by -18.46% on average. This is quite bad
USM shows a decrease in Revenue. In the last year, the revenue decreased by -3.94%.
USM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.31% yearly.
EPS 1Y (TTM)530.77%
EPS 3Y-37.59%
EPS 5Y-18.46%
EPS Q2Q%0%
Revenue 1Y (TTM)-3.94%
Revenue growth 3Y-1.09%
Revenue growth 5Y-0.31%
Sales Q2Q%-4.26%

3.2 Future

USM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.90% yearly.
The Revenue is expected to grow by 0.63% on average over the next years.
EPS Next Y-97.83%
EPS Next 2Y33.41%
EPS Next 3Y22.07%
EPS Next 5Y26.9%
Revenue Next Year-3.33%
Revenue Next 2Y-2.56%
Revenue Next 3Y-1.75%
Revenue Next 5Y0.63%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USM Yearly Revenue VS EstimatesUSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
USM Yearly EPS VS EstimatesUSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 79.78 indicates a quite expensive valuation of USM.
Compared to the rest of the industry, the Price/Earnings ratio of USM indicates a slightly more expensive valuation: USM is more expensive than 71.43% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. USM is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 59.29, which means the current valuation is very expensive for USM.
Based on the Price/Forward Earnings ratio, USM is valued more expensive than 80.95% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, USM is valued quite expensively.
Industry RankSector Rank
PE 79.78
Fwd PE 59.29
USM Price Earnings VS Forward Price EarningsUSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, USM is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
USM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. USM is more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.25
EV/EBITDA 9.98
USM Per share dataUSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

USM's earnings are expected to grow with 22.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.41%
EPS Next 3Y22.07%

0

5. Dividend

5.1 Amount

No dividends for USM!.
Industry RankSector Rank
Dividend Yield N/A

US CELLULAR CORP

NYSE:USM (2/21/2025, 8:04:00 PM)

After market: 65.42 0 (0%)

65.42

-1.63 (-2.43%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-21 2025-02-21/bmo
Earnings (Next)05-01 2025-05-01/bmo
Inst Owners26.28%
Inst Owner Change-6.55%
Ins Owners0.56%
Ins Owner Change1.91%
Market Cap5.63B
Analysts75.56
Price Target79.1 (20.91%)
Short Float %4.65%
Short Ratio6.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.33%
Min EPS beat(2)44.89%
Max EPS beat(2)95.76%
EPS beat(4)3
Avg EPS beat(4)104.24%
Min EPS beat(4)-27.29%
Max EPS beat(4)303.61%
EPS beat(8)5
Avg EPS beat(8)89.13%
EPS beat(12)7
Avg EPS beat(12)52.28%
EPS beat(16)9
Avg EPS beat(16)66.83%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.87%
Max Revenue beat(2)-0.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)0.6%
Revenue beat(8)1
Avg Revenue beat(8)-2.76%
Revenue beat(12)3
Avg Revenue beat(12)-1.89%
Revenue beat(16)5
Avg Revenue beat(16)-1.53%
PT rev (1m)0%
PT rev (3m)31.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-255.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-97.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 79.78
Fwd PE 59.29
P/S 1.48
P/FCF 24.25
P/OCF 6.2
P/B 1.23
P/tB 937.69
EV/EBITDA 9.98
EPS(TTM)0.82
EY1.25%
EPS(NY)1.1
Fwd EY1.69%
FCF(TTM)2.7
FCFY4.12%
OCF(TTM)10.56
OCFY16.14%
SpS44.17
BVpS53.28
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.29%
ROE -0.65%
ROCE 1.83%
ROIC 1.45%
ROICexc 1.49%
ROICexgc 2.92%
OM 4.63%
PM (TTM) N/A
GM 56.96%
FCFM 6.11%
ROA(3y)0.76%
ROA(5y)1.24%
ROE(3y)1.74%
ROE(5y)2.69%
ROIC(3y)1.18%
ROIC(5y)1.33%
ROICexc(3y)1.21%
ROICexc(5y)1.42%
ROICexgc(3y)2.26%
ROICexgc(5y)2.42%
ROCE(3y)1.5%
ROCE(5y)1.69%
ROICexcg growth 3Y-7.86%
ROICexcg growth 5Y-4.86%
ROICexc growth 3Y-14.73%
ROICexc growth 5Y-8.72%
OM growth 3Y-6.22%
OM growth 5Y0.84%
PM growth 3Y-37.54%
PM growth 5Y-18.23%
GM growth 3Y0.1%
GM growth 5Y0.31%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.51
Debt/EBITDA 3.43
Cap/Depr 101.65%
Cap/Sales 17.79%
Interest Coverage 250
Cash Conversion 107.97%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.39
Altman-Z 1.43
F-Score5
WACC7.52%
ROIC/WACC0.19
Cap/Depr(3y)193.63%
Cap/Depr(5y)176.24%
Cap/Sales(3y)32.17%
Cap/Sales(5y)29.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)530.77%
EPS 3Y-37.59%
EPS 5Y-18.46%
EPS Q2Q%0%
EPS Next Y-97.83%
EPS Next 2Y33.41%
EPS Next 3Y22.07%
EPS Next 5Y26.9%
Revenue 1Y (TTM)-3.94%
Revenue growth 3Y-1.09%
Revenue growth 5Y-0.31%
Sales Q2Q%-4.26%
Revenue Next Year-3.33%
Revenue Next 2Y-2.56%
Revenue Next 3Y-1.75%
Revenue Next 5Y0.63%
EBIT growth 1Y54.39%
EBIT growth 3Y-7.25%
EBIT growth 5Y0.53%
EBIT Next Year453.09%
EBIT Next 3Y76.59%
EBIT Next 5Y45.86%
FCF growth 1Y146.03%
FCF growth 3Y18.46%
FCF growth 5Y-7.5%
OCF growth 1Y15.37%
OCF growth 3Y-11.21%
OCF growth 5Y4.08%